Tom Inglesby, MD
Chief Executive Officer and Director
Dr. Inglesby is Director of the UPMC Center for Health Security. Since becoming Director in 2009, he has expanded and deepened the Center’s expertise related to public health threats, while also establishing new Center initiatives to build US preparedness for and resilience to emerging infectious diseases, natural disasters, nuclear terrorism, and nuclear accidents.
Dr. Inglesby’s work is internationally recognized in the fields of public health preparedness, pandemic flu planning, and biosecurity. He is Chair of the Board of Scientific Counselors, Office of Public Health Preparedness and Response, of the US Centers for Disease Control and Prevention. Dr. Inglesby has been chair or a member of a number of National Academy of Sciences committees, and he has served in an advisory capacity to the Defense Science Board, the Departments of Health and Human Services and Homeland Security, and the National Institutes of Health. He was a member of the National Academy of Sciences expert committee that reviewed the scientific approaches used during the investigation of the 2001 anthrax letters.
Dr. Inglesby has been invited to brief White House officials from the past 3 presidential administrations on national biosecurity challenges and priorities, and he has delivered Congressional testimony on public health preparedness and biosecurity.
Since 1999, Dr. Inglesby has authored or co-authored more than 80 peer-reviewed articles, reports, and commentaries on a wide range of public health and national security issues. In 2010, he co-authored “Necessary Progress in Biosecurity” with Senator Tom Daschle for the Harvard Law and Policy Review. He is Coeditor-in-Chief of the journal Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, which he helped to establish in 2003 as the first peer-reviewed journal in its field. In addition, Dr. Inglesby was principal editor of the 2002 JAMA book Bioterrorism: Guidelines for Medical and Public Health Management. He is regularly consulted by major news outlets for his expertise and insight on issues pertaining to biosecurity, pandemic flu planning biodefense, and response to other public health disasters.
Dr. Inglesby is Associate Professor of Medicine and Public Health at the University of Pittsburgh Schools of Medicine and Public Health. He completed his internal medicine and infectious diseases training at Johns Hopkins University School of Medicine, where he also served as Assistant Chief of Service in 1996-97. Dr. Inglesby received his MD from Columbia University College of Physicians and Surgeons and his BA from Georgetown University. He continues to see patients in a weekly HIV clinic.